Price controls always have undesirable short- and long-term consequences. Misguided policies like these will harm patients here in Connecticut.
Connecticut price controls will stifle biopharma innovation
A year ago it became clear the novel coronavirus and the disease it causes, COVID-19, would spread rapidly, far and wide, become a pandemic, and affect us much like a huge natural disaster or world war —millions of lost jobs, an economy derailed, resources redirected. We also witnessed firsthand how important and effective the biopharma industry is.
New medicines lower health-care costs
While some new drugs are costly, other new medicines represent an upfront, one-time cost to rid patients of vicious diseases that would ultimately cost the healthcare system far more in the long run.
CT opponents of GMO foods have misinformed, misled the public
For the past several years, opponents of genetically engineered products have misinformed and misled the general public with scare tactics and, sadly, an anti-science message. Connecticut has been a hot spot for this rhetoric, and unfortunately in 2013 our lawmakers chose to listen to fear rather than facts and passed unnecessary legislation regarding GMO labeling.